Tesla Q2 2024 earnings results: TSLA beats revenue, misses EPS estimates
Tesla (NASDAQ:TSLA) posted its Q2 2024 earnings report after markets closed today. The results, which were discussed in the Q2 2024 Update Letter, were released after the closing bell on Wednesday, July 23, 2024.
During the second quarter, Tesla produced 410,831 vehicles and delivered 443,956 vehicles worldwide, comprised of 422,405 Model 3 sedans and Model Y crossovers. In comparison, Wall Street analysts expected Tesla to report 438,019 vehicle deliveries.
Q2 2024 Shareholder Update → https://t.co/sXBSeLiJIj
— Highlights
We continued to expand our vehicle lineup globally, with new trims of Model 3 & Y as well as new S3XY paint options.
Vehicle
– Refreshed Model 3 ramp continued successfully
– We also continue to qualify more… pic.twitter.com/2UuLhlmjvD
— Tesla (@Tesla) July 23, 2024
The following is a quick overview of Tesla’s Q2 2024 earnings results.
REVENUE
In the second quarter of 2024, Tesla posted total revenues of $25.5 billion, with automotive revenues at $19.878 billion. FactSet consensus pointed to Tesla posting revenue of $24.5 billion in Q2 2024, while Zacks estimated Tesla to report $25.13 billion in revenue.
Overall, Tesla’s total revenue increased 2% year-over-year, thanks in part to factors such as growth in the company’s energy generation and storage business, Cybertruck deliveries, and higher regulatory credit revenue, among others.
EARNINGS PER SHARE
Tesla’s non-GAAP earnings per share for the second quarter of 2024 was listed at $0.52, while GAAP EPS for Q2 2024 was listed at $0.42. In comparison, FactSet consensus suggested that Tesla would see earnings per share of $0.61 and Zacks expected quarterly earnings of $0.62 per share.
PROFITABILITY
Tesla posted $1.6 billion GAAP operating income in Q2 after restructuring and other charges of $600 million. The electric vehicle maker saw $1.5 billion in GAAP net income and $1.8 billion non-GAAP net income in Q2 2024.
Tesla noted that its operating income decreased year-over-year to $1.6 billion in Q2, resulting in a 6.3% operating margin. This was due in part to reduced S3XY vehicle ASP, restructuring charges, and an increase in operating expenses largely driven by AI projects, to name a few.
CASH
Tesla’s quarter-end cash, cash equivalents, and investments in the second quarter of 2024 was $30.7 billion. The company noted that the sequential increase of $3.9 billion was the result of positive free cash flow of $1.3 billion, which was, in turn, driven by an inventory decrease of $1.8 billion and partially offset by AI infrastructure capex of $600 million in Q2 2024.
Tesla, however, highlighted that it has “sufficient liquidity to fund our product roadmap, long-term capacity expansion plans, and other expenses.” The company also noted that it “will manage the business such that we maintain a strong balance sheet during this uncertain period.”
Below is Tesla’s Q2 2024 Update Letter.
TSLA-Q2-2024-Update by Simon Alvarez on Scribd
Don’t hesitate to contact us with news tips. Just send a message to simon@teslarati.com to give us a heads up.
The post Tesla Q2 2024 earnings results: TSLA beats revenue, misses EPS estimates appeared first on TESLARATI.
Source: https://www.teslarati.com/tesla-q2-2024-earnings-results/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Lion’s Mane Mushroom Nootropic
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, But it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity.
Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins.
Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system.
Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome.
Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function.
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.
| Online: | |
| Visits: | 1,625,976,527 |
| Stories: | 8,214,570 |
Whistler Blowers, Insiders
